Axcelis invests $35M in new Korean facility
The Pyeongtaek site opens late 2028 to enhance ion implantation production and serve global semiconductor demand.
See the latest news and media coverage for Axcelis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Ion implantation equipment manufacturer for semiconductors
axcelis.comLast updated
In short: Axcelis approved a $4.4 billion merger with Veeco Instruments and announced a $35 million investment in a new South Korean facility.
The Pyeongtaek site opens late 2028 to enhance ion implantation production and serve global semiconductor demand.
The call takes place on August 6, 2026 at 8:30 AM EDT, with supporting Q2 earnings presentation available on the event page.
Filing date is August 6, 2026, for the quarter ended June 30, 2026.
Non-GAAP diluted EPS was $1.06 and GAAP diluted EPS was $0.75. The company issued Q3 2026 guidance of $230M revenue.
Axcelis shares fell 22.4% in a month as recovering bookings and demand collide with weaker margins, backlog pressure and heavy China exposure.
Beverly, Massachusetts, September 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS, a leading supplier of ion implantation solutions for the semiconductor industry) announced plans to build a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, South Korea, and invest $35 million in its global manufacturing infrastructure. CEO Ru...
In February, Axcelis reported a near 18% fall in 2025 sales to $839 million; this resulted in some deleveraging. GAAP ...
Research Analysts’ downgrades for Friday, August 7th: Axcelis Technologies (NASDAQ:ACLS) was downgraded by analysts at Craig Hallum from a buy rating to a hold rating...
Track Axcelis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Axcelis and other trending companies.